Literature DB >> 5338123

Treatment of obesity in underprivileged adolescents. Comparison of diethylpropion hydrochloride with placebo in a double-blind study.

M B Andelman, C Jones, S Nathan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 5338123     DOI： 10.1177/000992286700600607

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN： 0009-9228            Impact factor:   1.168


× No keyword cloud information.
  6 in total

Review 1.  Drug interventions for the treatment of obesity in children and adolescents.

Authors:  Emma Mead; Greg Atkinson; Bernd Richter; Maria-Inti Metzendorf; Louise Baur; Nicholas Finer; Eva Corpeleijn; Claire O'Malley; Louisa J Ells
Journal:  Cochrane Database Syst Rev       Date:  2016-11-29

Review 2.  The management of obesity.

Authors:  J M Court
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 3.  Pharmacotherapy for childhood obesity: present and future prospects.

Authors:  R Sherafat-Kazemzadeh; S Z Yanovski; J A Yanovski
Journal:  Int J Obes (Lond)       Date:  2012-08-28       Impact factor: 5.095

Review 4.  An evolving scientific basis for the prevention and treatment of pediatric obesity.

Authors:  P T Katzmarzyk; S Barlow; C Bouchard; P M Catalano; D S Hsia; T H Inge; C Lovelady; H Raynor; L M Redman; A E Staiano; D Spruijt-Metz; M E Symonds; M Vickers; D Wilfley; J A Yanovski
Journal:  Int J Obes (Lond)       Date:  2014-03-25       Impact factor: 5.095

5.  Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline.

Authors:  Dennis M Styne; Silva A Arslanian; Ellen L Connor; Ismaa Sadaf Farooqi; M Hassan Murad; Janet H Silverstein; Jack A Yanovski
Journal:  J Clin Endocrinol Metab       Date:  2017-03-01       Impact factor: 5.958

Review 6.  Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients.

Authors:  Rosa Camila Lucchetta; Bruno Salgado Riveros; Roberto Pontarolo; Rosana Bento Radominski; Michel Fleith Otuki; Fernando Fernandez-Llimos; Cassyano Januário Correr
Journal:  Clinics (Sao Paulo)       Date:  2017-05       Impact factor: 2.365
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.